FIRECREST Customer Support

Next- generation oncology therapies demand new thinking. Stop by booth ASCO, booth \#35093 to discuss how ICON integrates expertise, flexible partnership and delivery models, proven technology and global infrastructure...

ICON is participating in #AAPS NBC, taking place 11 - 14 May in San Diego. Be sure to visit booth \#404 to discuss how our comprehensive bioanalytical and early clinical manufacturing solutions can support your research ...

Achieving analytical clarity is critical to delivering high quality biosimilars. This spotlight examines emerging processes, CMC, strategic considerations and best practice frameworks shaping the future of bioanalysis. R...

ICON Biotech is exhibiting and presenting at #OCTEU26, 6–7 May in Barcelona. Visit booth \#52 to engage with the ICON team and learn how our biotech-focused solutions help sponsors navigate clinical development throughou...

First in human development of oligonucleotide drugs requires careful safety evaluation as molecular complexity increases. In this webinar, ICON specialists discuss best practices for FIH ON study design and risk mitiga...

Pediatric trials bring unique challenges, especially when choosing the best way to measure quality of life. We break down six key criteria to guide sponsors and assess how the PedsQL™ meets today’s expectations for globa...

Operational and safety protocols for neurologic monoclonal antibodies (mAbs) must be precisely matched to disease biology and operational strategy, including mandatory B‑cell and infection monitoring in multiple sclerosi...

Join ICON Biotech at OCT East Coast 2026, taking place 12–13 May 2026 at the Hyatt Regency New Brunswick, New Jersey. Meet our team at Booth \#25 and explore how our specialised clinical development services can suppor...

Are you working with NONMEM or PDx-Pop? Don’t miss the chance to connect with our team at PAGE in Croatia. Visit us at booth \#2 to: - Explore the latest features in NONMEM and PDx-Pop - Get expert insights on populati...

Heading to Philadelphia for #ISPORAnnual? Our ICON HEOR and RWE teams will be on-site sharing the latest thinking on patient-centred outcomes, comparative effectiveness research, and innovative evidence synthesis. Let’...

If recruitment and retention matter, site satisfaction must be treated as a prerequisite. In this Journal for Clinical Studies article, Brian Mallon explains why start-up success is shaped by human factors, not technolog...

We’re proud to share that Rose Kidd, President of Operational Delivery at ICON, has been recognised at the Women in Pharma Awards 2026, winning Excellence in senior leadership – life sciences. This award reflects Rose’...